Mutation in the Bacillus subtilis RNA polymerase β′ subunit confers resistance to lipiarmycin [2]

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 401-402

  Gualtieri, Maxime ^a   Villain Guillot, Philippe ^a   Latouche, Jaqueline ^a   Leonetti, Jean Paul ^a   Bastide, Lionel ^b  

^a University of Montpellier I and II   (France)

^b Selectbiotics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HOLOENZYME; LIPIARMYCIN; MACROCYCLIC COMPOUND; RNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACILLUS SUBTILIS; BETA CHAIN; CLOSTRIDIUM DIFFICILE; DIARRHEA; GENE MAPPING; GENE MUTATION; LETTER; POINT MUTATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; MUTATION;

EID: 29944444405     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.401-402.2006     Document Type: Letter

References (8)

1. Finegold, S., D. Molitoris, M. Vaisanen, Y. Song, C. Liu, and M. Bolanos. 2004. In vitro activities of OPT-80 and comparator drugs against intestinal bacteria. Antimicrob. Agents Chemother. 48:4898-4902.
2. Hochlowski, J., S. Swanson, L. Ranfranz, D. Whittern, A. Buko, and J. McAlpine. 1987. Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination. J. Antibiot. 40:575-588.
3. Murakami, K., S. Masuda, E. Campbell, O. Muzzin, and S. Darst. 2002. Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex. Science 296:1285-1290.
4. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M07-A6. NCCLS, Wayne, Pa.
5. Osburne, M., and A. Sonenshein. 1980. Inhibition by lipiarmycin of bacteriophage growth in Bacillus subtilis. J. Virol. 33:945-953.
6. Sonenshein, A., H. Alexander, D. Rothstein, and S. Fisher. 1977. Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis. J. Bacteriol. 132:73-79.
7. Swanson, R., D. Hardy, N. Shipkowitz, C. Hanson, N. Ramer, P. Fernandes, and J. Clement. 1991. In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Antimicrob. Agents Chemother. 35:1108-1111.
8. Talpaert, M., F. Campagnari, and L. Clerici. 1975. Lipiarmycin: an antibiotic inhibiting nucleic acid polymerases. Biochem. Biophys. Res. Commun. 63:328-334.